Skip to main content

Charlie

Analyst

Bank of America

Equibles does not estimate personal net worth.

About Charlie

Charlie is recorded as Analyst at Bank of America. Charlie has spoken on 2 earnings calls across 2 companies, most recently for Grifols SA on July 28, 2026. Those appearances were for Grifols SA (GRFS) and HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY. The companies whose calls Charlie spoke on are classified in the Healthcare sector.

Charlie on recent calls

“It's on the Sparta Alpha 1 trial with data end of the year. Could you frame your confidence in the outcome trial, given the data you've seen to date and any expectations for the 120 MIG or the 60 MIG dose?”
Analyst — Bank of America, Earnings conference call (announced in 6-K) ·
“First one's just, in our models, would it be reasonable to assume that a, I guess at this stage, a 30% midterm injectable margin is off the table given focus on profitable growth?”
Analyst — Bank of America, Full year 2025 results ·

Affiliation history

  • Bank of America

    Analyst

    Transcript header (unverified)

    Current

Company network

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY

Drug Manufacturers - Specialty & Generic · Healthcare

1 appearance Latest appearance 2026-02-26

Recent activity